Unlocking Immunotherapy Success: How Hematological Parameters Predict Outcomes in Advanced Non-Small Cell Lung Cancer
Lung cancer is the leading cause of cancer-related deaths globally, with nearly 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) accounts for approximately 80%–85% of all lung cancer cases. Most patients are diagnosed […]